U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry RACEMIC
Molecular Formula C19H18ClN3O3
Molecular Weight 371.818
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CAMAZEPAM

SMILES

CN(C)C(=O)OC1N=C(C2=CC=CC=C2)C3=CC(Cl)=CC=C3N(C)C1=O

InChI

InChIKey=PXBVEXGRHZFEOF-UHFFFAOYSA-N
InChI=1S/C19H18ClN3O3/c1-22(2)19(25)26-17-18(24)23(3)15-10-9-13(20)11-14(15)16(21-17)12-7-5-4-6-8-12/h4-11,17H,1-3H3

HIDE SMILES / InChI

Molecular Formula C19H18ClN3O3
Molecular Weight 371.818
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description

Camazepam is a benzodiazepine psychoactive drug, marketed under the brand names Albego, Limpidon and Paxor. It is the dimethyl carbamate ester of temazepam, a metabolite of diazepam. While it possesses anxiolytic, anticonvulsant, skeletal muscle relaxant and hypnotic properties it differs from other benzodiazepines in that its anxiolytic properties are particularly prominent but has comparatively limited anticonvulsant, hypnotic and skeletal muscle relaxant properties. Changes in sleep with camazepam were minimal. However, non-anxious subjects reported being more relaxed the next day. Camazepam may cause skin disorders.

Approval Year

PubMed

Sample Use Guides

In Vivo Use Guide
10, 20 and 40 mg overnight
Route of Administration: Oral
Substance Class Chemical
Record UNII
HZ3XRH03C3
Record Status Validated (UNII)
Record Version